nodes	percent_of_prediction	percent_of_DWPC	metapath
Permethrin—CYP2B6—Irinotecan—lung cancer	0.103	0.147	CbGbCtD
Permethrin—CYP2B6—Cisplatin—lung cancer	0.0842	0.12	CbGbCtD
Permethrin—CYP3A4—Topotecan—lung cancer	0.065	0.0926	CbGbCtD
Permethrin—CYP3A4—Gefitinib—lung cancer	0.0594	0.0847	CbGbCtD
Permethrin—CYP3A4—Teniposide—lung cancer	0.0576	0.0821	CbGbCtD
Permethrin—CYP2B6—Doxorubicin—lung cancer	0.0564	0.0804	CbGbCtD
Permethrin—CYP3A4—Vinorelbine—lung cancer	0.0458	0.0653	CbGbCtD
Permethrin—CYP3A4—Crizotinib—lung cancer	0.0364	0.0519	CbGbCtD
Permethrin—CYP3A4—Erlotinib—lung cancer	0.0351	0.0501	CbGbCtD
Permethrin—CYP3A4—Paclitaxel—lung cancer	0.0322	0.0459	CbGbCtD
Permethrin—CYP3A4—Irinotecan—lung cancer	0.0317	0.0452	CbGbCtD
Permethrin—CYP3A4—Vinblastine—lung cancer	0.0282	0.0402	CbGbCtD
Permethrin—CYP3A4—Etoposide—lung cancer	0.0254	0.0362	CbGbCtD
Permethrin—CYP3A4—Docetaxel—lung cancer	0.0233	0.0331	CbGbCtD
Permethrin—CYP3A4—Doxorubicin—lung cancer	0.0173	0.0247	CbGbCtD
Permethrin—Numbness—Vinblastine—lung cancer	0.00434	0.0227	CcSEcCtD
Permethrin—Sensory loss—Vinblastine—lung cancer	0.00415	0.0217	CcSEcCtD
Permethrin—Numbness—Vinorelbine—lung cancer	0.00361	0.0189	CcSEcCtD
Permethrin—Sensory loss—Vinorelbine—lung cancer	0.00345	0.0181	CcSEcCtD
Permethrin—Hypoaesthesia—Crizotinib—lung cancer	0.00318	0.0166	CcSEcCtD
Permethrin—Tingling sensation—Etoposide—lung cancer	0.00255	0.0133	CcSEcCtD
Permethrin—Erythema—Pemetrexed—lung cancer	0.00254	0.0133	CcSEcCtD
Permethrin—Tingling sensation—Paclitaxel—lung cancer	0.0025	0.0131	CcSEcCtD
Permethrin—Numbness—Etoposide—lung cancer	0.00247	0.0129	CcSEcCtD
Permethrin—Sensory loss—Etoposide—lung cancer	0.00237	0.0124	CcSEcCtD
Permethrin—Sensory loss—Paclitaxel—lung cancer	0.00232	0.0121	CcSEcCtD
Permethrin—Paraesthesia—Crizotinib—lung cancer	0.00204	0.0107	CcSEcCtD
Permethrin—Hypoaesthesia—Vinblastine—lung cancer	0.0018	0.0094	CcSEcCtD
Permethrin—Body temperature increased—Crizotinib—lung cancer	0.0018	0.0094	CcSEcCtD
Permethrin—Pain—Pemetrexed—lung cancer	0.00178	0.00929	CcSEcCtD
Permethrin—Pain—Gefitinib—lung cancer	0.00176	0.00923	CcSEcCtD
Permethrin—Hypoaesthesia—Topotecan—lung cancer	0.00175	0.00913	CcSEcCtD
Permethrin—Gastrointestinal pain—Pemetrexed—lung cancer	0.0017	0.00888	CcSEcCtD
Permethrin—Gastrointestinal pain—Gefitinib—lung cancer	0.00169	0.00883	CcSEcCtD
Permethrin—Abdominal pain—Pemetrexed—lung cancer	0.00164	0.00859	CcSEcCtD
Permethrin—Body temperature increased—Pemetrexed—lung cancer	0.00164	0.00859	CcSEcCtD
Permethrin—Body temperature increased—Gefitinib—lung cancer	0.00163	0.00853	CcSEcCtD
Permethrin—Abdominal pain—Gefitinib—lung cancer	0.00163	0.00853	CcSEcCtD
Permethrin—Diarrhoea—Crizotinib—lung cancer	0.00155	0.00813	CcSEcCtD
Permethrin—Erythema—Erlotinib—lung cancer	0.00151	0.00791	CcSEcCtD
Permethrin—Dizziness—Crizotinib—lung cancer	0.0015	0.00786	CcSEcCtD
Permethrin—Hypoaesthesia—Vinorelbine—lung cancer	0.00149	0.00781	CcSEcCtD
Permethrin—Pruritus—Pemetrexed—lung cancer	0.00147	0.00769	CcSEcCtD
Permethrin—Pruritus—Gefitinib—lung cancer	0.00146	0.00764	CcSEcCtD
Permethrin—Vomiting—Crizotinib—lung cancer	0.00144	0.00756	CcSEcCtD
Permethrin—Rash—Crizotinib—lung cancer	0.00143	0.00749	CcSEcCtD
Permethrin—Dermatitis—Crizotinib—lung cancer	0.00143	0.00749	CcSEcCtD
Permethrin—Diarrhoea—Pemetrexed—lung cancer	0.00142	0.00743	CcSEcCtD
Permethrin—Diarrhoea—Gefitinib—lung cancer	0.00141	0.00739	CcSEcCtD
Permethrin—Gastrointestinal pain—Teniposide—lung cancer	0.00138	0.0072	CcSEcCtD
Permethrin—Dizziness—Pemetrexed—lung cancer	0.00137	0.00718	CcSEcCtD
Permethrin—Nausea—Crizotinib—lung cancer	0.00135	0.00706	CcSEcCtD
Permethrin—Abdominal pain—Teniposide—lung cancer	0.00133	0.00696	CcSEcCtD
Permethrin—Body temperature increased—Teniposide—lung cancer	0.00133	0.00696	CcSEcCtD
Permethrin—Vomiting—Pemetrexed—lung cancer	0.00132	0.00691	CcSEcCtD
Permethrin—Stinging—Doxorubicin—lung cancer	0.00131	0.00687	CcSEcCtD
Permethrin—Vomiting—Gefitinib—lung cancer	0.00131	0.00686	CcSEcCtD
Permethrin—Rash—Pemetrexed—lung cancer	0.00131	0.00685	CcSEcCtD
Permethrin—Dermatitis—Pemetrexed—lung cancer	0.00131	0.00684	CcSEcCtD
Permethrin—Erythema—Vinorelbine—lung cancer	0.00131	0.00684	CcSEcCtD
Permethrin—Rash—Gefitinib—lung cancer	0.0013	0.00681	CcSEcCtD
Permethrin—Dermatitis—Gefitinib—lung cancer	0.0013	0.0068	CcSEcCtD
Permethrin—Nausea—Pemetrexed—lung cancer	0.00123	0.00645	CcSEcCtD
Permethrin—Nausea—Gefitinib—lung cancer	0.00123	0.00641	CcSEcCtD
Permethrin—Pruritus—Teniposide—lung cancer	0.00119	0.00623	CcSEcCtD
Permethrin—Paraesthesia—Vinblastine—lung cancer	0.00115	0.00603	CcSEcCtD
Permethrin—Diarrhoea—Teniposide—lung cancer	0.00115	0.00602	CcSEcCtD
Permethrin—Paraesthesia—Topotecan—lung cancer	0.00112	0.00586	CcSEcCtD
Permethrin—Pain—Vinblastine—lung cancer	0.0011	0.00574	CcSEcCtD
Permethrin—Vomiting—Teniposide—lung cancer	0.00107	0.00559	CcSEcCtD
Permethrin—Pain—Topotecan—lung cancer	0.00107	0.00558	CcSEcCtD
Permethrin—Rash—Teniposide—lung cancer	0.00106	0.00555	CcSEcCtD
Permethrin—Dermatitis—Teniposide—lung cancer	0.00106	0.00554	CcSEcCtD
Permethrin—Pain—Erlotinib—lung cancer	0.00105	0.00552	CcSEcCtD
Permethrin—Headache—Teniposide—lung cancer	0.00105	0.00551	CcSEcCtD
Permethrin—Erythema—Gemcitabine—lung cancer	0.00105	0.00549	CcSEcCtD
Permethrin—Gastrointestinal pain—Vinblastine—lung cancer	0.00105	0.00549	CcSEcCtD
Permethrin—Hypoaesthesia—Etoposide—lung cancer	0.00102	0.00536	CcSEcCtD
Permethrin—Gastrointestinal pain—Topotecan—lung cancer	0.00102	0.00533	CcSEcCtD
Permethrin—Abdominal pain—Vinblastine—lung cancer	0.00101	0.00531	CcSEcCtD
Permethrin—Gastrointestinal pain—Erlotinib—lung cancer	0.00101	0.00528	CcSEcCtD
Permethrin—Hypoaesthesia—Paclitaxel—lung cancer	0.001	0.00526	CcSEcCtD
Permethrin—Nausea—Teniposide—lung cancer	0.000999	0.00523	CcSEcCtD
Permethrin—Body temperature increased—Topotecan—lung cancer	0.000985	0.00516	CcSEcCtD
Permethrin—Abdominal pain—Topotecan—lung cancer	0.000985	0.00516	CcSEcCtD
Permethrin—Erythema—Cisplatin—lung cancer	0.000978	0.00512	CcSEcCtD
Permethrin—Body temperature increased—Erlotinib—lung cancer	0.000975	0.0051	CcSEcCtD
Permethrin—Abdominal pain—Erlotinib—lung cancer	0.000975	0.0051	CcSEcCtD
Permethrin—Paraesthesia—Vinorelbine—lung cancer	0.000958	0.00501	CcSEcCtD
Permethrin—Pain—Vinorelbine—lung cancer	0.000912	0.00477	CcSEcCtD
Permethrin—Pruritus—Topotecan—lung cancer	0.000882	0.00461	CcSEcCtD
Permethrin—Erythema—Paclitaxel—lung cancer	0.000879	0.0046	CcSEcCtD
Permethrin—Diarrhoea—Vinblastine—lung cancer	0.000878	0.00459	CcSEcCtD
Permethrin—Pruritus—Erlotinib—lung cancer	0.000873	0.00457	CcSEcCtD
Permethrin—Gastrointestinal pain—Vinorelbine—lung cancer	0.000872	0.00456	CcSEcCtD
Permethrin—Diarrhoea—Topotecan—lung cancer	0.000853	0.00446	CcSEcCtD
Permethrin—Hypoaesthesia—Docetaxel—lung cancer	0.000851	0.00445	CcSEcCtD
Permethrin—Dizziness—Vinblastine—lung cancer	0.000849	0.00444	CcSEcCtD
Permethrin—Diarrhoea—Erlotinib—lung cancer	0.000844	0.00442	CcSEcCtD
Permethrin—Abdominal pain—Vinorelbine—lung cancer	0.000843	0.00441	CcSEcCtD
Permethrin—Body temperature increased—Vinorelbine—lung cancer	0.000843	0.00441	CcSEcCtD
Permethrin—Dizziness—Topotecan—lung cancer	0.000824	0.00431	CcSEcCtD
Permethrin—Vomiting—Vinblastine—lung cancer	0.000816	0.00427	CcSEcCtD
Permethrin—Dizziness—Erlotinib—lung cancer	0.000816	0.00427	CcSEcCtD
Permethrin—Headache—Vinblastine—lung cancer	0.000804	0.00421	CcSEcCtD
Permethrin—Vomiting—Topotecan—lung cancer	0.000793	0.00415	CcSEcCtD
Permethrin—Paraesthesia—Irinotecan—lung cancer	0.00079	0.00413	CcSEcCtD
Permethrin—Rash—Topotecan—lung cancer	0.000786	0.00411	CcSEcCtD
Permethrin—Dermatitis—Topotecan—lung cancer	0.000785	0.00411	CcSEcCtD
Permethrin—Vomiting—Erlotinib—lung cancer	0.000784	0.0041	CcSEcCtD
Permethrin—Headache—Topotecan—lung cancer	0.000781	0.00409	CcSEcCtD
Permethrin—Rash—Erlotinib—lung cancer	0.000778	0.00407	CcSEcCtD
Permethrin—Dermatitis—Erlotinib—lung cancer	0.000777	0.00406	CcSEcCtD
Permethrin—Headache—Erlotinib—lung cancer	0.000773	0.00404	CcSEcCtD
Permethrin—Paraesthesia—Gemcitabine—lung cancer	0.000769	0.00402	CcSEcCtD
Permethrin—Nausea—Vinblastine—lung cancer	0.000762	0.00399	CcSEcCtD
Permethrin—Pruritus—Vinorelbine—lung cancer	0.000754	0.00395	CcSEcCtD
Permethrin—Pain—Irinotecan—lung cancer	0.000752	0.00393	CcSEcCtD
Permethrin—Erythema—Docetaxel—lung cancer	0.000745	0.0039	CcSEcCtD
Permethrin—Nausea—Topotecan—lung cancer	0.00074	0.00387	CcSEcCtD
Permethrin—Pain—Gemcitabine—lung cancer	0.000733	0.00383	CcSEcCtD
Permethrin—Nausea—Erlotinib—lung cancer	0.000733	0.00383	CcSEcCtD
Permethrin—Diarrhoea—Vinorelbine—lung cancer	0.00073	0.00382	CcSEcCtD
Permethrin—Gastrointestinal pain—Irinotecan—lung cancer	0.000719	0.00376	CcSEcCtD
Permethrin—Paraesthesia—Cisplatin—lung cancer	0.000717	0.00375	CcSEcCtD
Permethrin—Dizziness—Vinorelbine—lung cancer	0.000705	0.00369	CcSEcCtD
Permethrin—Abdominal pain—Irinotecan—lung cancer	0.000695	0.00364	CcSEcCtD
Permethrin—Body temperature increased—Irinotecan—lung cancer	0.000695	0.00364	CcSEcCtD
Permethrin—Pain—Cisplatin—lung cancer	0.000683	0.00357	CcSEcCtD
Permethrin—Vomiting—Vinorelbine—lung cancer	0.000678	0.00355	CcSEcCtD
Permethrin—Body temperature increased—Gemcitabine—lung cancer	0.000677	0.00354	CcSEcCtD
Permethrin—Rash—Vinorelbine—lung cancer	0.000672	0.00352	CcSEcCtD
Permethrin—Dermatitis—Vinorelbine—lung cancer	0.000672	0.00351	CcSEcCtD
Permethrin—Headache—Vinorelbine—lung cancer	0.000668	0.0035	CcSEcCtD
Permethrin—Paraesthesia—Etoposide—lung cancer	0.000657	0.00344	CcSEcCtD
Permethrin—Paraesthesia—Paclitaxel—lung cancer	0.000644	0.00337	CcSEcCtD
Permethrin—Nausea—Vinorelbine—lung cancer	0.000633	0.00331	CcSEcCtD
Permethrin—Body temperature increased—Cisplatin—lung cancer	0.000631	0.0033	CcSEcCtD
Permethrin—Pain—Etoposide—lung cancer	0.000626	0.00327	CcSEcCtD
Permethrin—Pain—Paclitaxel—lung cancer	0.000613	0.00321	CcSEcCtD
Permethrin—Pruritus—Gemcitabine—lung cancer	0.000606	0.00317	CcSEcCtD
Permethrin—Diarrhoea—Irinotecan—lung cancer	0.000602	0.00315	CcSEcCtD
Permethrin—Gastrointestinal pain—Etoposide—lung cancer	0.000598	0.00313	CcSEcCtD
Permethrin—Fenoprofen—PTGS2—lung cancer	0.000595	0.529	CrCbGaD
Permethrin—Gastrointestinal pain—Paclitaxel—lung cancer	0.000586	0.00307	CcSEcCtD
Permethrin—Diarrhoea—Gemcitabine—lung cancer	0.000586	0.00307	CcSEcCtD
Permethrin—Dizziness—Irinotecan—lung cancer	0.000582	0.00304	CcSEcCtD
Permethrin—Abdominal pain—Etoposide—lung cancer	0.000578	0.00303	CcSEcCtD
Permethrin—Body temperature increased—Etoposide—lung cancer	0.000578	0.00303	CcSEcCtD
Permethrin—Abdominal pain—Paclitaxel—lung cancer	0.000567	0.00297	CcSEcCtD
Permethrin—Body temperature increased—Paclitaxel—lung cancer	0.000567	0.00297	CcSEcCtD
Permethrin—Vomiting—Irinotecan—lung cancer	0.000559	0.00293	CcSEcCtD
Permethrin—Rash—Irinotecan—lung cancer	0.000554	0.0029	CcSEcCtD
Permethrin—Dermatitis—Irinotecan—lung cancer	0.000554	0.0029	CcSEcCtD
Permethrin—Headache—Irinotecan—lung cancer	0.000551	0.00288	CcSEcCtD
Permethrin—Diarrhoea—Cisplatin—lung cancer	0.000546	0.00286	CcSEcCtD
Permethrin—Paraesthesia—Docetaxel—lung cancer	0.000546	0.00286	CcSEcCtD
Permethrin—Vomiting—Gemcitabine—lung cancer	0.000545	0.00285	CcSEcCtD
Permethrin—Rash—Gemcitabine—lung cancer	0.00054	0.00283	CcSEcCtD
Permethrin—Dermatitis—Gemcitabine—lung cancer	0.00054	0.00282	CcSEcCtD
Permethrin—Erythema—Methotrexate—lung cancer	0.000537	0.00281	CcSEcCtD
Permethrin—Headache—Gemcitabine—lung cancer	0.000537	0.00281	CcSEcCtD
Permethrin—Hypoaesthesia—Doxorubicin—lung cancer	0.000531	0.00278	CcSEcCtD
Permethrin—Fenoprofen—ALB—lung cancer	0.000531	0.471	CrCbGaD
Permethrin—Nausea—Irinotecan—lung cancer	0.000522	0.00273	CcSEcCtD
Permethrin—Pain—Docetaxel—lung cancer	0.00052	0.00272	CcSEcCtD
Permethrin—Pruritus—Etoposide—lung cancer	0.000518	0.00271	CcSEcCtD
Permethrin—Nausea—Gemcitabine—lung cancer	0.000509	0.00266	CcSEcCtD
Permethrin—Vomiting—Cisplatin—lung cancer	0.000508	0.00266	CcSEcCtD
Permethrin—Pruritus—Paclitaxel—lung cancer	0.000507	0.00265	CcSEcCtD
Permethrin—Rash—Cisplatin—lung cancer	0.000503	0.00263	CcSEcCtD
Permethrin—Dermatitis—Cisplatin—lung cancer	0.000503	0.00263	CcSEcCtD
Permethrin—Diarrhoea—Etoposide—lung cancer	0.000501	0.00262	CcSEcCtD
Permethrin—Gastrointestinal pain—Docetaxel—lung cancer	0.000497	0.0026	CcSEcCtD
Permethrin—Diarrhoea—Paclitaxel—lung cancer	0.000491	0.00257	CcSEcCtD
Permethrin—Dizziness—Etoposide—lung cancer	0.000484	0.00253	CcSEcCtD
Permethrin—Body temperature increased—Docetaxel—lung cancer	0.000481	0.00251	CcSEcCtD
Permethrin—Abdominal pain—Docetaxel—lung cancer	0.000481	0.00251	CcSEcCtD
Permethrin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.000479	0.00452	CbGpPWpGaD
Permethrin—Dizziness—Paclitaxel—lung cancer	0.000474	0.00248	CcSEcCtD
Permethrin—Nausea—Cisplatin—lung cancer	0.000474	0.00248	CcSEcCtD
Permethrin—CYP2B6—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000473	0.00446	CbGpPWpGaD
Permethrin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—lung cancer	0.000466	0.00439	CbGpPWpGaD
Permethrin—Vomiting—Etoposide—lung cancer	0.000465	0.00243	CcSEcCtD
Permethrin—Erythema—Doxorubicin—lung cancer	0.000465	0.00243	CcSEcCtD
Permethrin—CYP2B6—Biological oxidations—CNDP2—lung cancer	0.000462	0.00435	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—GSTM2—lung cancer	0.000462	0.00435	CbGpPWpGaD
Permethrin—Rash—Etoposide—lung cancer	0.000461	0.00241	CcSEcCtD
Permethrin—Dermatitis—Etoposide—lung cancer	0.000461	0.00241	CcSEcCtD
Permethrin—Headache—Etoposide—lung cancer	0.000458	0.0024	CcSEcCtD
Permethrin—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000457	0.00431	CbGpPWpGaD
Permethrin—Vomiting—Paclitaxel—lung cancer	0.000456	0.00239	CcSEcCtD
Permethrin—CYP2B6—Metapathway biotransformation—GSTM2—lung cancer	0.000456	0.00429	CbGpPWpGaD
Permethrin—Rash—Paclitaxel—lung cancer	0.000452	0.00237	CcSEcCtD
Permethrin—Dermatitis—Paclitaxel—lung cancer	0.000452	0.00236	CcSEcCtD
Permethrin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—lung cancer	0.000451	0.00424	CbGpPWpGaD
Permethrin—Headache—Paclitaxel—lung cancer	0.000449	0.00235	CcSEcCtD
Permethrin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.000441	0.00415	CbGpPWpGaD
Permethrin—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.000435	0.0041	CbGpPWpGaD
Permethrin—Nausea—Etoposide—lung cancer	0.000435	0.00227	CcSEcCtD
Permethrin—CYP3A4—Estrogen metabolism—GSTM1—lung cancer	0.000432	0.00407	CbGpPWpGaD
Permethrin—Pruritus—Docetaxel—lung cancer	0.00043	0.00225	CcSEcCtD
Permethrin—Nausea—Paclitaxel—lung cancer	0.000426	0.00223	CcSEcCtD
Permethrin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	0.000424	0.00399	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—CYP2A7—lung cancer	0.000418	0.00394	CbGpPWpGaD
Permethrin—Diarrhoea—Docetaxel—lung cancer	0.000416	0.00218	CcSEcCtD
Permethrin—CYP2B6—Metapathway biotransformation—CYP2A7—lung cancer	0.000412	0.00388	CbGpPWpGaD
Permethrin—CYP3A4—Estrogen metabolism—CYP1A1—lung cancer	0.00041	0.00386	CbGpPWpGaD
Permethrin—Dizziness—Docetaxel—lung cancer	0.000402	0.0021	CcSEcCtD
Permethrin—Paraesthesia—Methotrexate—lung cancer	0.000393	0.00206	CcSEcCtD
Permethrin—CYP3A4—Irinotecan Pathway—APC—lung cancer	0.000393	0.0037	CbGpPWpGaD
Permethrin—CYP2B6—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000389	0.00366	CbGpPWpGaD
Permethrin—Vomiting—Docetaxel—lung cancer	0.000387	0.00202	CcSEcCtD
Permethrin—SCN1A—Developmental Biology—SOX2—lung cancer	0.000385	0.00363	CbGpPWpGaD
Permethrin—Rash—Docetaxel—lung cancer	0.000383	0.00201	CcSEcCtD
Permethrin—Dermatitis—Docetaxel—lung cancer	0.000383	0.002	CcSEcCtD
Permethrin—Headache—Docetaxel—lung cancer	0.000381	0.00199	CcSEcCtD
Permethrin—CYP3A4—Xenobiotics—CYP1A1—lung cancer	0.000377	0.00355	CbGpPWpGaD
Permethrin—Pain—Methotrexate—lung cancer	0.000375	0.00196	CcSEcCtD
Permethrin—CYP2B6—Biological oxidations—GSTA3—lung cancer	0.000372	0.00351	CbGpPWpGaD
Permethrin—CYP2B6—Metapathway biotransformation—GSTA3—lung cancer	0.000367	0.00346	CbGpPWpGaD
Permethrin—CYP3A4—Tamoxifen metabolism—CYP1A1—lung cancer	0.000362	0.00341	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—NCOA3—lung cancer	0.000362	0.00341	CbGpPWpGaD
Permethrin—Nausea—Docetaxel—lung cancer	0.000361	0.00189	CcSEcCtD
Permethrin—SCN1A—L1CAM interactions—SRC—lung cancer	0.000361	0.0034	CbGpPWpGaD
Permethrin—Gastrointestinal pain—Methotrexate—lung cancer	0.000358	0.00187	CcSEcCtD
Permethrin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.000358	0.00337	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—NCAM1—lung cancer	0.000352	0.00332	CbGpPWpGaD
Permethrin—Body temperature increased—Methotrexate—lung cancer	0.000346	0.00181	CcSEcCtD
Permethrin—Abdominal pain—Methotrexate—lung cancer	0.000346	0.00181	CcSEcCtD
Permethrin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000344	0.00324	CbGpPWpGaD
Permethrin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.000343	0.00323	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—GSTA4—lung cancer	0.000341	0.00321	CbGpPWpGaD
Permethrin—Paraesthesia—Doxorubicin—lung cancer	0.000341	0.00178	CcSEcCtD
Permethrin—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.00034	0.0032	CbGpPWpGaD
Permethrin—CYP2B6—Metapathway biotransformation—GSTA4—lung cancer	0.000336	0.00317	CbGpPWpGaD
Permethrin—SCN1A—L1CAM interactions—MAPK3—lung cancer	0.000333	0.00313	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—GSTA2—lung cancer	0.000332	0.00313	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—ITGB1—lung cancer	0.000327	0.00308	CbGpPWpGaD
Permethrin—Pain—Doxorubicin—lung cancer	0.000324	0.0017	CcSEcCtD
Permethrin—CYP2B6—Biological oxidations—GSTA1—lung cancer	0.00032	0.00302	CbGpPWpGaD
Permethrin—SCN1A—L1CAM interactions—EGFR—lung cancer	0.000316	0.00298	CbGpPWpGaD
Permethrin—Gastrointestinal pain—Doxorubicin—lung cancer	0.00031	0.00162	CcSEcCtD
Permethrin—Pruritus—Methotrexate—lung cancer	0.00031	0.00162	CcSEcCtD
Permethrin—CYP2B6—Metapathway biotransformation—AKR1C1—lung cancer	0.000303	0.00285	CbGpPWpGaD
Permethrin—Body temperature increased—Doxorubicin—lung cancer	0.0003	0.00157	CcSEcCtD
Permethrin—Abdominal pain—Doxorubicin—lung cancer	0.0003	0.00157	CcSEcCtD
Permethrin—Diarrhoea—Methotrexate—lung cancer	0.0003	0.00157	CcSEcCtD
Permethrin—CYP2B6—Biological oxidations—UGT1A1—lung cancer	0.000298	0.00281	CbGpPWpGaD
Permethrin—CYP2B6—Metapathway biotransformation—UGT1A1—lung cancer	0.000294	0.00277	CbGpPWpGaD
Permethrin—Dizziness—Methotrexate—lung cancer	0.00029	0.00152	CcSEcCtD
Permethrin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	0.000281	0.00265	CbGpPWpGaD
Permethrin—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000279	0.00263	CbGpPWpGaD
Permethrin—Vomiting—Methotrexate—lung cancer	0.000279	0.00146	CcSEcCtD
Permethrin—Rash—Methotrexate—lung cancer	0.000276	0.00145	CcSEcCtD
Permethrin—Dermatitis—Methotrexate—lung cancer	0.000276	0.00144	CcSEcCtD
Permethrin—Headache—Methotrexate—lung cancer	0.000274	0.00144	CcSEcCtD
Permethrin—CYP3A4—Tryptophan metabolism—CYP2E1—lung cancer	0.000269	0.00254	CbGpPWpGaD
Permethrin—Pruritus—Doxorubicin—lung cancer	0.000268	0.0014	CcSEcCtD
Permethrin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	0.000268	0.00252	CbGpPWpGaD
Permethrin—Nausea—Methotrexate—lung cancer	0.00026	0.00136	CcSEcCtD
Permethrin—Diarrhoea—Doxorubicin—lung cancer	0.00026	0.00136	CcSEcCtD
Permethrin—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000257	0.00242	CbGpPWpGaD
Permethrin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.000256	0.00241	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—FGFR1—lung cancer	0.000256	0.00241	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—HPGDS—lung cancer	0.000253	0.00239	CbGpPWpGaD
Permethrin—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000253	0.00238	CbGpPWpGaD
Permethrin—Dizziness—Doxorubicin—lung cancer	0.000251	0.00131	CcSEcCtD
Permethrin—CYP2B6—Biological oxidations—GSTT1—lung cancer	0.000246	0.00231	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—CYP2A6—lung cancer	0.000243	0.00229	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—GCLC—lung cancer	0.000243	0.00229	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—FOXO3—lung cancer	0.000242	0.00228	CbGpPWpGaD
Permethrin—Vomiting—Doxorubicin—lung cancer	0.000241	0.00126	CcSEcCtD
Permethrin—SCN1A—Axon guidance—KDR—lung cancer	0.000241	0.00227	CbGpPWpGaD
Permethrin—Rash—Doxorubicin—lung cancer	0.000239	0.00125	CcSEcCtD
Permethrin—Dermatitis—Doxorubicin—lung cancer	0.000239	0.00125	CcSEcCtD
Permethrin—Headache—Doxorubicin—lung cancer	0.000238	0.00124	CcSEcCtD
Permethrin—SCN1A—Axon guidance—MET—lung cancer	0.000236	0.00222	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—ITGB1—lung cancer	0.000233	0.0022	CbGpPWpGaD
Permethrin—Nausea—Doxorubicin—lung cancer	0.000225	0.00118	CcSEcCtD
Permethrin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.000218	0.00205	CbGpPWpGaD
Permethrin—CYP3A4—Tryptophan metabolism—CAT—lung cancer	0.000216	0.00204	CbGpPWpGaD
Permethrin—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000215	0.00202	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—HES1—lung cancer	0.000215	0.00202	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—CNDP2—lung cancer	0.00021	0.00198	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—GSTM2—lung cancer	0.00021	0.00198	CbGpPWpGaD
Permethrin—CYP2B6—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.000208	0.00196	CbGpPWpGaD
Permethrin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000208	0.00196	CbGpPWpGaD
Permethrin—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	0.000207	0.00195	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—CYP2E1—lung cancer	0.000206	0.00194	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—IL6R—lung cancer	0.000206	0.00194	CbGpPWpGaD
Permethrin—CYP2B6—Metapathway biotransformation—CYP2E1—lung cancer	0.000204	0.00192	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—MMP2—lung cancer	0.000197	0.00185	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—MAP2K1—lung cancer	0.000197	0.00185	CbGpPWpGaD
Permethrin—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	0.000194	0.00182	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—CYP2A7—lung cancer	0.00019	0.00179	CbGpPWpGaD
Permethrin—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	0.000187	0.00176	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—FGFR1—lung cancer	0.000183	0.00172	CbGpPWpGaD
Permethrin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000177	0.00166	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—RAF1—lung cancer	0.000174	0.00164	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—ERBB2—lung cancer	0.000173	0.00163	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—KDR—lung cancer	0.000172	0.00162	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—GSTP1—lung cancer	0.00017	0.0016	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—GSTA3—lung cancer	0.000169	0.00159	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—MET—lung cancer	0.000168	0.00159	CbGpPWpGaD
Permethrin—CYP2B6—Metapathway biotransformation—GSTP1—lung cancer	0.000168	0.00158	CbGpPWpGaD
Permethrin—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	0.000167	0.00157	CbGpPWpGaD
Permethrin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000156	0.00147	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—GSTM1—lung cancer	0.000156	0.00147	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—GSTA4—lung cancer	0.000155	0.00146	CbGpPWpGaD
Permethrin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000154	0.00145	CbGpPWpGaD
Permethrin—CYP2B6—Metapathway biotransformation—GSTM1—lung cancer	0.000154	0.00145	CbGpPWpGaD
Permethrin—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	0.000153	0.00144	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—GSTA2—lung cancer	0.000151	0.00142	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—CYP1A1—lung cancer	0.000148	0.0014	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—MMP9—lung cancer	0.000148	0.00139	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—IL6R—lung cancer	0.000147	0.00139	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—CREBBP—lung cancer	0.000147	0.00138	CbGpPWpGaD
Permethrin—CYP2B6—Metapathway biotransformation—CYP1A1—lung cancer	0.000146	0.00138	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—GSTA1—lung cancer	0.000146	0.00137	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—MMP2—lung cancer	0.00014	0.00132	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—MAP2K1—lung cancer	0.00014	0.00132	CbGpPWpGaD
Permethrin—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	0.000137	0.0013	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—SRC—lung cancer	0.000136	0.00129	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—UGT1A1—lung cancer	0.000135	0.00127	CbGpPWpGaD
Permethrin—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	0.000133	0.00126	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—VEGFA—lung cancer	0.000133	0.00125	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—NRAS—lung cancer	0.000131	0.00124	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—AZIN2—lung cancer	0.00013	0.00123	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—COL4A3BP—lung cancer	0.00013	0.00123	CbGpPWpGaD
Permethrin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000127	0.0012	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—MAPK3—lung cancer	0.000126	0.00118	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—RAF1—lung cancer	0.000124	0.00117	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—ERBB2—lung cancer	0.000123	0.00116	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—EGFR—lung cancer	0.00012	0.00113	CbGpPWpGaD
Permethrin—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	0.000119	0.00112	CbGpPWpGaD
Permethrin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000117	0.0011	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—HPGDS—lung cancer	0.000115	0.00108	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—KRAS—lung cancer	0.000113	0.00106	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—GSTT1—lung cancer	0.000112	0.00105	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—ATP5H—lung cancer	0.000111	0.00104	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—POMC—lung cancer	0.000111	0.00104	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—CYP2A6—lung cancer	0.00011	0.00104	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—GCLC—lung cancer	0.00011	0.00104	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—MMP9—lung cancer	0.000106	0.000995	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—EP300—lung cancer	0.0001	0.000943	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—PLBD1—lung cancer	9.89e-05	0.000931	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—SRC—lung cancer	9.74e-05	0.000917	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—HRAS—lung cancer	9.6e-05	0.000905	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—VEGFA—lung cancer	9.48e-05	0.000893	CbGpPWpGaD
Permethrin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	9.46e-05	0.000891	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—STAT3—lung cancer	9.39e-05	0.000884	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—CYP2E1—lung cancer	9.38e-05	0.000884	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—NRAS—lung cancer	9.37e-05	0.000882	CbGpPWpGaD
Permethrin—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	9.25e-05	0.000871	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—IL6—lung cancer	9.19e-05	0.000866	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—HSD17B10—lung cancer	9.04e-05	0.000852	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—MAPK3—lung cancer	8.97e-05	0.000845	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—EGFR—lung cancer	8.53e-05	0.000804	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—CKB—lung cancer	8.41e-05	0.000792	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—KRAS—lung cancer	8.06e-05	0.000759	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—CNDP2—lung cancer	7.9e-05	0.000744	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—GSTM2—lung cancer	7.9e-05	0.000744	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—GSTP1—lung cancer	7.74e-05	0.000729	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—MTMR3—lung cancer	7.69e-05	0.000724	CbGpPWpGaD
Permethrin—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	7.63e-05	0.000719	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—PGAM1—lung cancer	7.49e-05	0.000706	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—CYP2A7—lung cancer	7.15e-05	0.000673	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—GSTM1—lung cancer	7.11e-05	0.00067	CbGpPWpGaD
Permethrin—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	7.01e-05	0.00066	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—SDC4—lung cancer	6.99e-05	0.000659	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—HRAS—lung cancer	6.85e-05	0.000645	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—CYP1A1—lung cancer	6.74e-05	0.000635	CbGpPWpGaD
Permethrin—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	6.65e-05	0.000626	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—IL6—lung cancer	6.56e-05	0.000618	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—RRM1—lung cancer	6.37e-05	0.0006	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—GSTA3—lung cancer	6.37e-05	0.0006	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—AKT1—lung cancer	6.05e-05	0.00057	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—B4GALT5—lung cancer	5.99e-05	0.000564	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—COL4A3BP—lung cancer	5.93e-05	0.000558	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—AZIN2—lung cancer	5.93e-05	0.000558	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—GSTA4—lung cancer	5.83e-05	0.000549	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—GSTA2—lung cancer	5.68e-05	0.000535	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—GSTA1—lung cancer	5.48e-05	0.000516	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—ABCC3—lung cancer	5.42e-05	0.00051	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—AKR1C1—lung cancer	5.25e-05	0.000494	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—UGT1A1—lung cancer	5.09e-05	0.00048	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—ATP5H—lung cancer	5.04e-05	0.000475	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—POMC—lung cancer	5.02e-05	0.000473	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—GNG11—lung cancer	4.91e-05	0.000463	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—ALDOA—lung cancer	4.68e-05	0.00044	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—NCOA3—lung cancer	4.54e-05	0.000428	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—PLBD1—lung cancer	4.49e-05	0.000423	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—ADCY1—lung cancer	4.42e-05	0.000416	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—ABCG2—lung cancer	4.42e-05	0.000416	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—HPGDS—lung cancer	4.33e-05	0.000408	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—ENO2—lung cancer	4.33e-05	0.000408	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—PPP2R1B—lung cancer	4.3e-05	0.000405	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—GSTT1—lung cancer	4.2e-05	0.000396	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—GCLC—lung cancer	4.15e-05	0.000391	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—CYP2A6—lung cancer	4.15e-05	0.000391	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—HSD17B10—lung cancer	4.11e-05	0.000387	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—ENO1—lung cancer	3.94e-05	0.000371	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—CKB—lung cancer	3.82e-05	0.00036	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—CNDP2—lung cancer	3.59e-05	0.000338	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—GSTM2—lung cancer	3.59e-05	0.000338	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—CYP2E1—lung cancer	3.53e-05	0.000333	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—MTMR3—lung cancer	3.49e-05	0.000329	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—NQO1—lung cancer	3.49e-05	0.000329	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—PGAM1—lung cancer	3.4e-05	0.000321	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—CYP2A7—lung cancer	3.25e-05	0.000306	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—SDC4—lung cancer	3.18e-05	0.000299	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—STK11—lung cancer	3.15e-05	0.000296	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—GSTP1—lung cancer	2.91e-05	0.000274	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—GSTA3—lung cancer	2.89e-05	0.000273	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—RRM1—lung cancer	2.89e-05	0.000273	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—CAT—lung cancer	2.83e-05	0.000267	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—ABCB1—lung cancer	2.76e-05	0.00026	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—B4GALT5—lung cancer	2.72e-05	0.000256	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—TYMS—lung cancer	2.71e-05	0.000255	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—GSTM1—lung cancer	2.68e-05	0.000252	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—GSTA4—lung cancer	2.65e-05	0.000249	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—GSTA2—lung cancer	2.58e-05	0.000243	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—CYP1A1—lung cancer	2.54e-05	0.000239	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—ERCC2—lung cancer	2.52e-05	0.000237	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—GSTA1—lung cancer	2.49e-05	0.000234	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—ABCC3—lung cancer	2.46e-05	0.000232	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—AKR1C1—lung cancer	2.38e-05	0.000225	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—UGT1A1—lung cancer	2.31e-05	0.000218	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—GNG11—lung cancer	2.23e-05	0.00021	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—APOA1—lung cancer	2.18e-05	0.000205	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—ALDOA—lung cancer	2.12e-05	0.0002	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—NCOA3—lung cancer	2.06e-05	0.000194	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—ADCY1—lung cancer	2.01e-05	0.000189	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—ABCG2—lung cancer	2.01e-05	0.000189	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—PIK3CG—lung cancer	1.99e-05	0.000187	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—ENO2—lung cancer	1.97e-05	0.000185	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—HPGDS—lung cancer	1.97e-05	0.000185	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.96e-05	0.000184	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—GSTT1—lung cancer	1.91e-05	0.00018	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—POMC—lung cancer	1.89e-05	0.000178	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—CYP2A6—lung cancer	1.89e-05	0.000178	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—GCLC—lung cancer	1.89e-05	0.000178	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—CREBBP—lung cancer	1.84e-05	0.000173	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—ENO1—lung cancer	1.79e-05	0.000168	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—PIK3CD—lung cancer	1.75e-05	0.000165	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—ALB—lung cancer	1.72e-05	0.000162	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—CYP2E1—lung cancer	1.6e-05	0.000151	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—NQO1—lung cancer	1.59e-05	0.000149	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—PIK3CB—lung cancer	1.52e-05	0.000143	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—PTGS2—lung cancer	1.51e-05	0.000142	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—STK11—lung cancer	1.43e-05	0.000135	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—GSTP1—lung cancer	1.32e-05	0.000125	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—PTEN—lung cancer	1.32e-05	0.000124	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—CAT—lung cancer	1.29e-05	0.000121	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—EP300—lung cancer	1.25e-05	0.000118	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—ABCB1—lung cancer	1.25e-05	0.000118	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—TYMS—lung cancer	1.23e-05	0.000116	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—GSTM1—lung cancer	1.22e-05	0.000115	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—CYP1A1—lung cancer	1.15e-05	0.000109	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—ERCC2—lung cancer	1.14e-05	0.000108	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—APOA1—lung cancer	9.89e-06	9.31e-05	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—PIK3CA—lung cancer	9.28e-06	8.74e-05	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—PIK3CG—lung cancer	9.03e-06	8.5e-05	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—POMC—lung cancer	8.59e-06	8.09e-05	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—CREBBP—lung cancer	8.37e-06	7.88e-05	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—PIK3CD—lung cancer	7.94e-06	7.48e-05	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—ALB—lung cancer	7.83e-06	7.38e-05	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—AKT1—lung cancer	7.58e-06	7.14e-05	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—PIK3CB—lung cancer	6.92e-06	6.52e-05	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—PTGS2—lung cancer	6.85e-06	6.46e-05	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—PTEN—lung cancer	5.98e-06	5.63e-05	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—EP300—lung cancer	5.7e-06	5.37e-05	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—PIK3CA—lung cancer	4.22e-06	3.97e-05	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—AKT1—lung cancer	3.44e-06	3.24e-05	CbGpPWpGaD
